Impact of early administration of empagliflozin in patients with acute decompensated heart failure on medium-term prognosis (3 and 6 months)

Aim. To evaluate the impact of early administration of empagliflozin — from the first day of treatment of acute decompensated heart failure (ADHF) on outcomes at 3 and 6 months.Material and methods. The study included 92 patients admitted to the hospital with ADHF without hemodynamic instability. On...

ver descrição completa

Detalhes bibliográficos

Principais autores:	D. P. Golubovskaya, V. N. Karetnikova, O. L. Barbarash
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Столичная издательская компания 2025-10-01
coleção:	Рациональная фармакотерапия в кардиологии
Assuntos:	acute decompensated heart failure empagliflozin gliflozins sodium-glucose cotransporter 2 inhibitors safety prognosis
Acesso em linha:	https://www.rpcardio.online/jour/article/view/3174
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!